UNCY
Unicycive Therapeutics Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$6.83
-0.18 ▼ -2.57%
🌙 3월 13일 4:40 PM ET (한국 3/14 05:40)
$6.80
-0.03 ▼ -0.44%
| Index | - | P/E | - | EPS (ttm) | -3.25 | Insider Own | 11.26% | Shs Outstand | 0.02B | Perf Week | 3.64% |
| Market Cap | 0.15B | Forward P/E | 0.99 | EPS next Y | 638.73% | Insider Trans | - | Shs Float | 0.02B | Perf Month | 9.28% |
| Enterprise Value | 0.10B | PEG | - | EPS next Q | -0.47 | Inst Own | 42.33% | Short Float | 10.28% | Perf Quarter | 3.64% |
| Income | -0.03B | P/S | - | EPS this Y | 77.21% | Inst Trans | 2.95% | Short Ratio | 3.71 | Perf Half Y | 66.99% |
| Sales | 0.00B | P/B | 3.8 | EPS next 5Y | - | ROA | -75.06% | Short Interest | 1.96M | Perf YTD | 18.37% |
| Book/sh | 1.8 | P/C | 3.44 | EPS past 3/5Y | 5.45% -31.8% | ROE | -102.47% | 52W High | -37.91% ($11.00) | Perf Year | 17.29% |
| Cash/sh | 1.99 | P/FCF | - | Sales past 3/5Y | - | ROIC | -89.31% | 52W Low | 84.1% ($3.71) | Perf 3Y | -68.53% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 66.05% | Gross Margin | - | Volatility(W/M) | 5.27% 5.34% | Perf 5Y | - |
| Dividend TTM | - | EV/Sales | - | Sales Y/Y TTM | -100% | Oper. Margin | - | ATR (14) | 0.39 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 3.83 | EPS Q/Q | 27.75% | Profit Margin | - | RSI (14) | 52.16 | Recom | 1 |
| Dividend Gr. 3/5Y | - | Current Ratio | 3.83 | Sales Q/Q | - | SMA20 | 1.44% ($6.73) | Beta | 1.8 | Target Price | $46.5 |
| Payout | - | Debt/Eq | 0.01 | Earnings | 11000000 | SMA50 | 4.85% ($6.51) | Rel Volume | 0.72 | Prev Close | $7.01 |
| Employees | 22 | LT Debt/Eq | 0 | EPS/Sales Surpr. | 37.74% - | SMA200 | 24.79% ($5.47) | Avg Volume(3M) | 0.53M | Price | $6.83 |
| IPO | 2021/7/13 | Option/Short | Yes/Yes | Trades | 3328 | Volume | 382,717 | Change | -2.57% |
뉴스 로딩 중...